Resources

Publications

01/21/2025
- Oncology
Concordance Between Human Epidermal Growth Factor Receptor 2 (HER2) Status by Immunohistochemistry (IHC) and Next-Generation Sequencing (NGS) in Tissue and Blood Samples From Gastric and Gastroesophageal Junction Cancers (GC/GEJC)
ASCO GI 2025
01/21/2025
- Oncology
Association Between Ex Vivo Pharmacotyping of Patient-Derived Tumor Organoids and Personalized Therapeutic Options for Patients With Biliary Tract Cancer
ASCO GI 2025
01/21/2025
- Oncology
Molecular Characteristics of Early-Onset Versus Average-Onset Gastroesophageal Adenocarcinoma
ASCO GI 2025
01/18/2025
- Oncology
Hypofractionated Radiation Therapy for Subcutaneous Rosai-Dorfman Disease: A Case Report
Advances in Radiation Oncology
01/08/2025
- Cardiology
Development and Validation of a Moderate Aortic Stenosis Disease Progression Model
Intelligence-Based Medicine
12/10/2024
- Oncology
Efficient and Generalizable Prediction of Molecular Alterations in Multiple-Cancer Cohorts Using Hematoxylin and Eosin Whole Slide Images
Modern Pathology
12/06/2024
- Oncology
Optimizing Clinical Trial Subject Selection: Insights from Exigent Research Network and the Tempus AI TIME Program Collaboration
AI in Precision Oncology
12/03/2024
- Oncology
Tumor-Derived CCL2 Drives Tumor Growth and Immunosuppression in IDH1-Mutant Cholangiocarcinoma
Hepatology
12/03/2024
- Oncology
Tremelimumab and Durvalumab as Neoadjuvant or Non-Operative Management Strategy of Patients With Microsatellite Instability-High Resectable Gastric or Gastroesophageal Junction Adenocarcinoma: The INFINITY Study by GONO
Annals of Oncology
11/25/2024
- Oncology
Multicenter Retrospective Cohort Study of the Sequential Use of Antibody Drug Conjugates Trastuzumab Deruxtecan & Sacituzumab Govitecan in Patients With HER2 Low Metastatic Breast Cancer: A Subgroup Analysis of Next Generation Sequencing Results.
SABCS 2024

11 12 13